Clinical Outcomes of HER2‐Low Versus HER2‐Zero in HR‐Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study

International Journal of Breast Cancer · Published 2025-01-01 · DOI 10.1155/ijbc/5597051

Authors being retrieved — see the publisher record. https://doi.org/10.1155/ijbc/5597051

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Machine learning and cox model–based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 − metastatic breast cancer: a multicenter real-world study · Breast Cancer Research and Treatment · 2026 · Cites or is cited by this article
• Elevated Serum Vitamin B12 Levels as a Potential Biomarker for Solid Tumors in Jordanian Patients: A Retrospective Case–Control Study · International Journal of Breast Cancer · 2026 · Same journal
• Enhancing Rural Breast Cancer Screening Uptake: A Three‐Arm Comparative Study of Outreach Strategies · International Journal of Breast Cancer · 2026 · Same journal
• The Role of Angiogenesis in Breast Cancer and Obesity: Unravelling the Connection · International Journal of Breast Cancer · 2026 · Same journal
• Triple‐Negative Breast Cancer: Tumor Immunogenicity and Beyond · International Journal of Breast Cancer · 2024 · Same journal
• Comparing Disease‐Free Survival (DFS) and Overall Survival (OS) Rates in Breast Cancer Patients: Axillary Lymph Node Dissection (ALND) Versus Sentinel Lymph Node Biopsy (SLNB) · International Journal of Breast Cancer · 2026 · Same journal
• MicroRNA-326 as a Tumor Suppressor Regulates the NOB1 Expression in Breast Cancer · International Journal of Breast Cancer · 2026 · Same journal
• Male Breast Cancer: An Updated Review of Patient Characteristics, Genetics, and Outcome · International Journal of Breast Cancer · 2024 · Same journal
• Labels, Language, and Other Strategies to Improve Communication About Lower Grade Forms of Ductal Carcinoma In Situ of the Breast: A National Delphi Survey · International Journal of Breast Cancer · 2025 · Same journal
• Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer · International Journal of Breast Cancer · 2025 · Same journal